AB
Ashwani Bhalla
About Ashwani Bhalla
Data last updated:
Ashwani Bhalla is a Whole-Time Director at Drbest Pharmaceuticals Private Limited (since 2016), Director at Wagnerhuber Pharmaceuticals Private Limited (since 2010) and Director at Proton Pharma Private Limited (since 2012). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹9.70 Cr; the largest is Drbest Pharmaceuticals Private Limited at ₹7.34 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 15 Jan 2016 | 2016 | ₹7.34 Cr (FY 2024) | Active | |
| Director | 12 Apr 2010 | 2010 | ₹2.36 Cr (FY 2025) | Active | |
| Director | 22 May 2012 | 2012 | Active |
Board colleagues of Ashwani Bhalla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rajesh Dhingra | 00988957 | Drbest Pharmaceuticals Private Limited | Managing Director |
| Sumit Kumar | 07711843 | Wagnerhuber Pharmaceuticals Private Limited | Director |
| Virender Kumar | 08097550 | Wagnerhuber Pharmaceuticals Private Limited | Whole-Time Director |
| Sumit Tandon | 07342992 | Proton Pharma Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashwani Bhalla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashwani Bhalla
Ashwani Bhalla currently holds 3 directorships: Drbest Pharmaceuticals Private Limited (Whole-Time Director, since 15 Jan 2016, revenue ₹7.34 Cr (FY 2024)); Wagnerhuber Pharmaceuticals Private Limited (Director, since 12 Apr 2010, revenue ₹2.36 Cr (FY 2025)); Proton Pharma Private Limited (Director, since 22 May 2012).
Ashwani Bhalla was first appointed on 12 Apr 2010 as Director at Wagnerhuber Pharmaceuticals Private Limited. The most recent appointment on record is 15 Jan 2016 at Drbest Pharmaceuticals Private Limited.
The 2 current companies of Ashwani Bhalla that report revenue have a combined latest revenue of ₹9.70 Cr: Drbest Pharmaceuticals Private Limited ₹7.34 Cr (FY 2024); Wagnerhuber Pharmaceuticals Private Limited ₹2.36 Cr (FY 2025).
The current boards of Ashwani Bhalla's companies include Rajesh Dhingra (Drbest Pharmaceuticals Private Limited), Sumit Kumar (Wagnerhuber Pharmaceuticals Private Limited), Virender Kumar (Wagnerhuber Pharmaceuticals Private Limited), Sumit Tandon (Proton Pharma Private Limited).